Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02909192 · ClinicalTrials.gov registry record · NA

Bright Light Therapy for Non-motor Symptoms in Parkinson's Disease

A NA study of Parkinson's Disease, sponsored by Massachusetts General Hospital.

Active
Registry status
NA
Development phase
65
Enrollment target
1
Study location

NCT02909192: Active NA study of Parkinson's Disease, sponsored by Massachusetts General Hospital.

NCT02909192 is a NA study of Parkinson's Disease that is active but no longer recruiting, run by Massachusetts General Hospital. The registered enrollment target is 65 participants, below the 635-participant average among 158 other Parkinson's Disease trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02909192, a NA study of Parkinson's Disease, is active but no longer recruiting, sponsored by Massachusetts General Hospital.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
65 participants
Enrollment target
1
Study location

Study Summary

Disruption of sleep and alertness is one of the most disabling non-motor symptoms of Parkinson's disease (PD). Mechanisms leading to impaired sleep and alertness in PD are not well understood, and treatment options remain limited. The proposed research will examine markers of the circadian system, sleepiness and sleep quality in PD patients. Further, the project will examine effects of bright light exposure on circadin function, sleep and alertness in PD.

Conditions Studied

Interventions

  • DEVICE Light Therapy Device

Study Locations (1)

Massachusetts

  • Massachusetts General Hospital - Boston

Trial Details

FieldValue
Enrollment Target 65 participants
Start Date 2016-12
Est. Completion 2026-11
Phase NA
Massachusetts General Hospital

2,032 total trials

What the registry record for NCT02909192 still lists

NCT02909192 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 65 participants, a relatively small participant target, below the 635-participant average among 158 other Parkinson's Disease trials with a reported enrollment target (90% lower).

The record links to 1 condition, with Parkinson's Disease appearing as the primary indexed condition, and to 1 intervention - of which Light Therapy Device is the first listed.

NCT02909192 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT02909192 about?

NCT02909192 is a clinical study titled "Bright Light Therapy for Non-motor Symptoms in Parkinson's Disease". Disruption of sleep and alertness is one of the most disabling non-motor symptoms of Parkinson's disease (PD). Mechanisms leading to impaired sleep and alertness in PD are not well understood, and treatment options remain limited. The proposed research will examine markers of the circadian system, s...

What is the current status of trial NCT02909192?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 65 participants. The study started on 2016-12. Estimated completion is 2026-11.

What conditions does trial NCT02909192 study?

This clinical trial studies the following conditions: Parkinson's Disease.

What interventions are being tested in trial NCT02909192?

The interventions under investigation include: Light Therapy Device (DEVICE).

Who is sponsoring clinical trial NCT02909192?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02909192 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Parkinson's Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02909192's enrollment target sits among peer trials

65 71st of 158 higher than 88 of 158 other Parkinson's Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Parkinson's Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03366116 · 65 participants · Phase 1

    5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors

  • NCT03603730 · 65 participants · NA

    Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis

  • NCT03796559 · 65 participants · NA

    Magseed Enabled Long-Term Localization of Axillary Lymph Nodes

  • NCT03993106 · 65 participants · Phase 2

    A Study of sEphB4-HSA in Kaposi Sarcoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02909192, the US trial registry maintained by the National Library of Medicine. NCT02909192 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.